From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries

BACKGROUND: Coverage decisions determining the benefit baskets of health systems have been increasingly relying on evidence regarding patient benefit and costs. Relevant structures, methodologies, and processes have especially been established for pharmaceuticals but approaches differ. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Panteli, Dimitra, Eckhardt, Helene, Nolting, Alexandra, Busse, Reinhard, Kulig, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583728/
https://www.ncbi.nlm.nih.gov/pubmed/26407728
http://dx.doi.org/10.1186/s12961-015-0028-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583728/
https://www.ncbi.nlm.nih.gov/pubmed/26407728
http://dx.doi.org/10.1186/s12961-015-0028-5

Ejemplares similares